Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 25c

Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.25), $0.25 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• UBS Downgrades Collins Foods Ltd. (CKF:AU) (CLLFF) to Neutral
• JPMorgan Reinstates Adidas AG (ADS:GR) (ADDYY) at Overweight